<DOC>
	<DOCNO>NCT00003419</DOCNO>
	<brief_summary>RATIONALE : HIV virus find lesion patient Kaposi 's sarcoma , may role cause Kaposi 's sarcoma . Antiviral therapy act HIV virus may effective treatment Kaposi 's sarcoma . PURPOSE : This phase II trial study well antiviral therapy work treat patient slowly progress HIV-related Kaposi 's sarcoma .</brief_summary>
	<brief_title>Antiviral Therapy Treating Patients With Slowly Progressing HIV-Related Kaposi 's Sarcoma</brief_title>
	<detailed_description>OBJECTIVES : - Determine efficacy highly active antiretroviral therapy ( HAART ) treat patient HIV-related stage I-III nonaggressive epidemic Kaposi 's sarcoma . OUTLINE : Patients receive therapy consist nucleoside analogue ( RTI ) protease inhibitor ( PI ) . Patients may receive either 2 RTIs 2 RTIs plus 2 PIs . Treatment continue 12 week , progression assess . Patients stable regress Kaposi 's sarcoma ( KS ) viral load great 500 copy RNA/mL may continue therapy ( viral load decrease great 2 log ) may modify therapy ( viral load decrease less 2 log ) . Patients progressive disease may begin chemotherapy continue receive antiretroviral therapy . Treatment continue least 48 week . Patients follow every 8 week week 48 . PROJECTED ACCRUAL : This study accrue total 14-25 patient .</detailed_description>
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Sarcoma , Kaposi</mesh_term>
	<mesh_term>Antiviral Agents</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Stage IIII ( NYU ) Kaposi 's sarcoma slowly progressive Stable disease without progression diameter tumor number lesion ( less 50 % increase 3 month ) No progressive disease treatment Kaposi 's sarcoma Level viral load detectable independently CD4+ cell No active AIDS pathology PATIENT CHARACTERISTICS : Age : 18 Performance status : ECOG 03 Life expectancy : Not specify Hematopoietic : WBC great 1500/mm3 Hemoglobin great 8 mg/dL Hepatic : Bilirubin le 2.5 time normal AST ALT less 5 time normal Alkaline phosphatase less 2.5 time normal Renal : Creatinine le 2.5 time normal Other : No prior malignancy except carcinoma situ cervix nonmelanomatous skin cancer No active cytomegalovirus , herpes simplex 1 2 , herpes zoster infection require treatment PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : Not specify Endocrine therapy : Not specify Radiotherapy : Not specify Surgery : Not specify Other No prior antiretroviral therapy OR No prior highly active antiretroviral therapy ( HAART ) No concurrent acyclovir , ganciclovir , foscarnet , cidofovir</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2001</verification_date>
	<keyword>AIDS-related Kaposi sarcoma</keyword>
</DOC>